Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway.

Cheng, Fang; Yang, Fuji; Wang, Yanjin; Zhou, Jing; Qian, Hui; Yan, Yongmin

Cheng, Fang; Yang, Fuji; Wang, Yanjin; Zhou, Jing; Qian, Hui; Yan, Yongmin.

Afiliação

Cheng F; Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Jiangsu University, Changzhou, 213017, China.
Yang F; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212001, China.
Wang Y; Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Jiangsu University, Changzhou, 213017, China.
Zhou J; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212001, China.
Qian H; Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Jiangsu University, Changzhou, 213017, China.
Yan Y; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212001, China.

J Nanobiotechnology ; 21(1): 195, 2023 Jun 16.

Article em En | MEDLINE | ID: mdl-37328872

Assuntos

Células-Tronco Mesenquimais; MicroRNAs; Humanos; Colágeno/metabolismo; Hibridização in Situ Fluorescente; Cirrose Hepática/induzido quimicamente; Cirrose Hepática/tratamento farmacológico; Cirrose Hepática/metabolismo; Células-Tronco Mesenquimais/metabolismo; MicroRNAs/metabolismo

Palavras-chave

Collagen crosslinking; Exosome; LOXL2; Liver fibrosis; MSC; YAP; miR-27b-3p

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Células-Tronco Mesenquimais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google